Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in bladder cancer biology and therapy
Linda L. Tran, Jin-Fen Xiao, Neeraj Agarwal, et al.
Nature reviews. Cancer (2020) Vol. 21, Iss. 2, pp. 104-121
Open Access | Times Cited: 518

Showing 1-25 of 518 citing articles:

Bladder cancer
Lars Dyrskjøt, Donna E. Hansel, Jason A. Efstathiou, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 179
Advances in diagnosis and treatment of bladder cancer
Antonio López-Beltrán, Michael S. Cookson, Brendan J. Guercio, et al.
BMJ (2024), pp. e076743-e076743
Open Access | Times Cited: 160
LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer
Wenjie Luo, Jun Wang, Wenhao Xu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 143
An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer
Kenneth Gouin, Nathan Ing, Jasmine Plummer, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 124
Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer
Zikun Ma, Xiangdong Li, Yize Mao, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1550-1565.e7
Open Access | Times Cited: 121
Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer
Qiang Song, Rui Zhou, Fangpeng Shu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 118
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
Ming Chi, Jiao Liu, Chenxue Mei, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 99
Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer
Ana Julia Aguiar de Freitas, Rhafaela Lima Causin, Muriele Bertagna Varuzza, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9952-9952
Open Access | Times Cited: 76
ETV4 Mediated Tumor‐Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer
Qiang Zhang, Sen Liu, Hongjin Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 11
Open Access | Times Cited: 73
m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization
Ning Wang, Rixin Chen, Minhua Deng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 55
The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I–Mediated Immune Response
Lei Zhang, Yuqing Li, Lingli Zhou, et al.
Cancer Research (2023) Vol. 83, Iss. 11, pp. 1834-1850
Open Access | Times Cited: 44
Integrated multiomics analysis and machine learning refine molecular subtypes and prognosis for muscle-invasive urothelial cancer
Guangdi Chu, Xiaoyu Ji, Yonghua Wang, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 110-126
Open Access | Times Cited: 44
Carbon nanotube-mediated platinum-based drug delivery for the treatment of cancer: Advancements and future perspectives
Mohammad Sameer Khan, B.H. Jaswanth Gowda, Nazeer Hasan, et al.
European Polymer Journal (2024) Vol. 206, pp. 112800-112800
Closed Access | Times Cited: 27
Knockdown of integrin β1 inhibits proliferation and promotes apoptosis in bladder cancer cells
Jin‐feng Wang, Jianshe Wang, Yang Liu, et al.
BioFactors (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 17
Clinical advances of mRNA vaccines for cancer immunotherapy
Alexey V. Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, et al.
Med (2025) Vol. 6, Iss. 1, pp. 100562-100562
Closed Access | Times Cited: 6
Single‐cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer
Huadong Lai, Xiaomu Cheng, Qiang Liu, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 12, pp. 2099-2115
Open Access | Times Cited: 83
Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation
Yu‐Cheng Chin, Li‐Xing Yang, Fei‐Ting Hsu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 62
Advances in Diagnosis and Therapy for Bladder Cancer
Xinzi Hu, Guangzhi Li, Song Wu
Cancers (2022) Vol. 14, Iss. 13, pp. 3181-3181
Open Access | Times Cited: 42
Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer
Manli Wang, Xuelan Chen, Ping Tan, et al.
Cancer Cell (2022) Vol. 40, Iss. 9, pp. 1044-1059.e8
Open Access | Times Cited: 41
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)
Jonathan E. Rosenberg, Se Hoon Park, Vadim Kozlov, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 1, pp. 43-53
Open Access | Times Cited: 39
Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers
Mi‐Young Son, Hyun‐Soo Cho
Journal of Microbiology and Biotechnology (2023) Vol. 33, Iss. 7, pp. 849-856
Open Access | Times Cited: 38
Biomedical Micro‐/Nanomotors: Design, Imaging, and Disease Treatment
Wei Liu, Ya Liu, He Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 15
Closed Access | Times Cited: 36
Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies
Amirreza Mehmandar‐Oskuie, Kasra Jahankhani, Arman Rostamlou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115242-115242
Open Access | Times Cited: 29
CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis
Shuangqing Liu, Zehan Liu, Aichen Shang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 28
The androgen receptor in bladder cancer
Jinbo Chen, Chi‐Ping Huang, Chao Quan, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 9, pp. 560-574
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top